DICLOXACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Dicloxacillin patents expire, and what generic alternatives are available?
Dicloxacillin is a drug marketed by Aurobindo Pharma, Chartwell Rx, Teva, and Apothecon. and is included in four NDAs.
The generic ingredient in DICLOXACILLIN is dicloxacillin sodium. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dicloxacillin
A generic version of DICLOXACILLIN was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DICLOXACILLIN?
- What are the global sales for DICLOXACILLIN?
- What is Average Wholesale Price for DICLOXACILLIN?
Summary for DICLOXACILLIN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for DICLOXACILLIN |
| DailyMed Link: | DICLOXACILLIN at DailyMed |
US Patents and Regulatory Information for DICLOXACILLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | DICLOXACILLIN SODIUM | dicloxacillin sodium | CAPSULE;ORAL | 216845-001 | Sep 23, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva | DICLOXACILLIN SODIUM | dicloxacillin sodium | CAPSULE;ORAL | 062286-002 | Jun 3, 1982 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | DICLOXACILLIN SODIUM | dicloxacillin sodium | CAPSULE;ORAL | 061454-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | DICLOXACILLIN SODIUM | dicloxacillin sodium | FOR SUSPENSION;ORAL | 061455-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
